Outpatient initiation of direct-to-inject buprenorphine
In this retrospective study, DTI buprenorphine initiation demonstrated favorable tolerability and retention in a high-risk population across diverse outpatient settings. This approach may offer a viable pathway to long-acting buprenorphine treatment for individuals using fentanyl who may not tolerate traditional initiation methods.
Authors
- Sarah Rosenwohl-Mack (ORCID: https://orcid.org/0000-0002-2885-9605)
- Lysa Samuel
- Lauren K. Roller
- Leslie W. Suen (ORCID: https://orcid.org/0000-0003-4786-356X)
- Hannah R. Snyder (ORCID: https://orcid.org/0000-0002-8120-3824)
- Alexander R. Bazazi (ORCID: https://orcid.org/0000-0002-4284-5082)
- Megan Heeney (ORCID: https://orcid.org/0009-0008-3034-0897)
- Erik S. Anderson (ORCID: https://orcid.org/0000-0001-7759-4327)
- Damian Peterson (ORCID: https://orcid.org/0000-0002-6670-0726)
- Andrew A. Herring
Institutions
- San Francisco General Hospital (US)
- University of California, San Francisco (US)
- Alameda Health System (US)
- San Francisco Department of Public Health (US)
Publication Details
- Journal
- Drug and Alcohol Dependence
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1016/j.drugalcdep.2025.113011
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00